AbCellera Biologics
ABCL
ABCL
142 hedge funds and large institutions have $682M invested in AbCellera Biologics in 2023 Q4 according to their latest regulatory filings, with 26 funds opening new positions, 46 increasing their positions, 36 reducing their positions, and 20 closing their positions.
Holders
142
Holders Change
+4
Holders Change %
+2.9%
% of All Funds
2.08%
Holding in Top 10
4
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.06%
New
26
Increased
46
Reduced
36
Closed
20
Calls
$7.64M
Puts
$2.85M
Net Calls
+$4.79M
Net Calls Change
+$702K
Top Buyers
| 1 |
BBA
1
Baker Bros. Advisors
New York
|
$131M |
| 2 |
2
Fidelity International
Hamilton,
Bermuda
|
$10.7M |
| 3 |
3
BlackRock
New York
|
$22.3M |
| 4 |
4
Goldman Sachs
New York
|
$3.43M |
| 5 |
5
Two Sigma Advisers
New York
|
$5.67M |
